Bashar Hana Saqat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bashar Hana Saqat has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Aram Baram
Branch of Clinical Sciences, College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq
2 shared publications - Dezhin Faeq Rashid
Kurdistan Board for Medical Specialties Trainee, Cardiothoracic and Vascular Surgery, Kurdistan Region, Iraq
1 shared publication Kizhan H. AbdullahSalih
Kurdistan Board Med Specialties Trainee, Cardiothorac & Vasc Surg, Sulaimani, Kurdistan Regio, Iraq
1 shared publication
Latest Publications
- Open Access
- 2 July 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104036
Non-randomized comparative study of three methods for great saphenous vein ablation associated with mini-phlebectomy; 48 months clinical and sonographic outcome
Varicose veins are one of the earliest clinical features of superficial venous insufficiency (SVI) of the lower limbs that affects around 20–40% of the population with a lot of burden on patients’ quality of life (QoL) and health systems if left untreated. They are defined as subcutaneous veins in the lower extremities which are dilated to ≥3 mm in diameter in the upright position and retrograde flow of >0.5 s in duration. (VVs) could occur in the great saphenous vein (GSV) or small saphenous vein (SSV) and/or in any of their tributaries. A prospective non-randomized comparative study for three methods of treatment of varicose veins was conducted. All symptomatic varicose veins with Clinical, Etiological, Anatomical, Pathophysiological (CEAP) Clinical classes of 2 or greater and demonstrated venous reflux with a duration of 0.5 s or greater on duplex ultrasound imaging GSV larger than 10 mm in diameter by duplex ultrasound were included. A total of 150 patients with 183 legs in all three groups are treated. The mean age of the patients in all groups was comparable (37.32) years, and a total of 87% were women. Demographic and preoperative clinical features, presentations, and anatomic characteristics were comparable in all groups. Disfigurement was the main presenting complaint in all. All postoperative complications were significantly higher in the group of surgery over 48 months of follow up the degree of satisfaction measured by VCSS score was highest among the RFA group followed by the EVLA group. The results of our study suggest that the long-term results of endovenous thermal ablation methods (EVLA, RFA) are superior to open surgery for the management of varicose veins, with the RFA group showing better results in terms of improvement in QoL based on VCSS compared to the EVLA group.
- 2 July 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104036
Open AccessNon-randomized comparative study of three methods for great saphenous vein ablation associated with mini-phlebectomy; 48 months clinical and sonographic outcome
Varicose veins are one of the earliest clinical features of superficial venous insufficiency (SVI) of the lower limbs that affects around 20–40% of the population with a lot of burden on patients’ quality of life (QoL) and health systems if left untreated. They are defined as subcutaneous veins in the lower extremities which are dilated to ≥3 mm in diameter in the upright position and retrograde flow of >0.5 s in duration. (VVs) could occur in the great saphenous vein (GSV) or small saphenous vein (SSV) and/or in any of their tributaries. A prospective non-randomized comparative study for three methods of treatment of varicose veins was conducted. All symptomatic varicose veins with Clinical, Etiological, Anatomical, Pathophysiological (CEAP) Clinical classes of 2 or greater and demonstrated venous reflux with a duration of 0.5 s or greater on duplex ultrasound imaging GSV larger than 10 mm in diameter by duplex ultrasound were included. A total of 150 patients with 183 legs in all three groups are treated. The mean age of the patients in all groups was comparable (37.32) years, and a total of 87% were women. Demographic and preoperative clinical features, presentations, and anatomic characteristics were comparable in all groups. Disfigurement was the main presenting complaint in all. All postoperative complications were significantly higher in the group of surgery over 48 months of follow up the degree of satisfaction measured by VCSS score was highest among the RFA group followed by the EVLA group. The results of our study suggest that the long-term results of endovenous thermal ablation methods (EVLA, RFA) are superior to open surgery for the management of varicose veins, with the RFA group showing better results in terms of improvement in QoL based on VCSS compared to the EVLA group.
- Open Access
- 1 September 2021
- Published by Wolters Kluwer Health in International Journal of Surgery Open
- Vol. 35
Thymectomy for non-thymomatous myasthenia gravis: Short and long term outcomes, a single-center 10 years' experience
: Background: Myasthenia gravis (MG) is an auto-immune disorder characterized by the production of abnormal antibodies to the acetylcholine receptors at the neuromuscular junction. Radical thymectomy in many forms of MG may lead to clinical improvement in 70–80% of cases. Our objectives were to demonstrate our short and long-term results of radical trans-sternal thymectomy. Patients and methods: Retrospective analysis of prospectively collected data from 48 consecutive patients with non-thymomatous MG, managed over 10 years. All patients with thymomatous MG were excluded. The myasthenia gravis activities of daily living (MG-ADL) scoring performed for all patients and the stage of disease determined by the Myasthenia Gravis Foundation of America (MGFA) classification. The primary endpoint of this study was to evaluate early first 30 days postoperative outcomes and the secondary endpoint was to determine complete stable remission, time of pharmacological remission, and decreasing MG-ADL scoring over 5 years follow-up. Results: Totally, 48 patients included: 41 females (85.4%) and 7 males (14.5%). Generalized muscle weakness, shortness of breath, and easy fatigability were the most common presenting features. During 5 years follow up, 38 patients (79.1%) had decreased their medication dose. Time of pharmacological remission started (6–60) months. Complete stable remission (CSR) achieved in 44 patients (91.6%) over 60 months. Post-operative MG-ADL levels ranged between (12–24) scores, at the end of the follow-up period decrease to less than 10 scores. Conclusion: Radical trans-sternal thymectomy for non-thymomatous MG is an effective and well-tolerated procedure that is associated with significant clinical improvement in the majority of patients. Highlights:
- 1 September 2021
- Published by Wolters Kluwer Health in International Journal of Surgery Open
- Vol. 35
Open AccessThymectomy for non-thymomatous myasthenia gravis: Short and long term outcomes, a single-center 10 years' experience
: Background: Myasthenia gravis (MG) is an auto-immune disorder characterized by the production of abnormal antibodies to the acetylcholine receptors at the neuromuscular junction. Radical thymectomy in many forms of MG may lead to clinical improvement in 70–80% of cases. Our objectives were to demonstrate our short and long-term results of radical trans-sternal thymectomy. Patients and methods: Retrospective analysis of prospectively collected data from 48 consecutive patients with non-thymomatous MG, managed over 10 years. All patients with thymomatous MG were excluded. The myasthenia gravis activities of daily living (MG-ADL) scoring performed for all patients and the stage of disease determined by the Myasthenia Gravis Foundation of America (MGFA) classification. The primary endpoint of this study was to evaluate early first 30 days postoperative outcomes and the secondary endpoint was to determine complete stable remission, time of pharmacological remission, and decreasing MG-ADL scoring over 5 years follow-up. Results: Totally, 48 patients included: 41 females (85.4%) and 7 males (14.5%). Generalized muscle weakness, shortness of breath, and easy fatigability were the most common presenting features. During 5 years follow up, 38 patients (79.1%) had decreased their medication dose. Time of pharmacological remission started (6–60) months. Complete stable remission (CSR) achieved in 44 patients (91.6%) over 60 months. Post-operative MG-ADL levels ranged between (12–24) scores, at the end of the follow-up period decrease to less than 10 scores. Conclusion: Radical trans-sternal thymectomy for non-thymomatous MG is an effective and well-tolerated procedure that is associated with significant clinical improvement in the majority of patients. Highlights: